We found 127 records for "Legal"

Articles

Data, ethics and anonymisation in a changing digital communications world

19th May 2015

 Data, ethics and anonymisation in a changing digital communications worldArticles

This is the last in a series of three articles examining the legal and ethical dilemmas faced when using new mediums and data sources for healthcare market research and data...

Read more

A new era of transparency: UK pharma prepares to publish doctor payments

5th May 2015

 A new era of transparency: UK pharma prepares to publish doctor paymentsArticles

Pharma companies across Europe are gearing up to disclose for the first time the names of health professionals and healthcare organisations who they have made payments to. In the first...

Read more

Protecting the future: the regenerative medicine evolution

10th March 2015

 Protecting the future: the regenerative medicine evolutionArticles

Regenerative medicine has left the realms of sci-fi to become a practical, new form of technology, which can give patients amazing results with serious, previously untreatable injuries. However, the legalities...

Read more

We need to talk about ChemSex: risks of Hep C and HIV are high

2nd March 2015

 We need to talk about ChemSex: risks of Hep C and HIV are highArticles

More gay men in the UK are presenting to clinicians with complicated issues associated with drug use and consent to sex in ChemSex environments (taking recreational drugs during sex and...

Read more

News

Novartis and Juno settle CAR-T patent dispute

7th April 2015

 Novartis and Juno settle CAR-T patent disputeNews

Novartis and Juno Therapeutics have settled a patent dispute centring on CAR-T therapies - one of the most anticipated research areas in the hot topic of cancer immunotherapy.The agreement gives...

Read more

Amgen fails to block Neupogen biosimilar

20th March 2015

 Amgen fails to block Neupogen biosimilarNews

Amgen has failed in a legal attempt to block the sale of a biosimilar version of its white blood cell stimulator Neupogen developed by Novartis' Sandoz subsidiary.The biosimilar – called...

Read more

Tough times ahead in US market for Glaxo and AZ

17th February 2015

 Tough times ahead in US market for Glaxo and AZNews

GlaxoSmithKline has replaced the head of its North American business unit as it struggles to maintain sales in its biggest market.Meanwhile, AstraZeneca has also been dealt a major blow to its...

Read more

US doctor faces jail in pharma bribery case

16th February 2015

 US doctor faces jail in pharma bribery caseNews

A US doctor is facing a jail sentence after pleading guilty to over-prescribing a hazardous anti-psychotic drug to patients in return for kickbacks.71-year-old Michael Reinstein from Chicago admitted to accepting...

Read more

Events

Viral Safety & Raw Materials Congress

24th June 2015 - 25th June 2015

Viral Safety & Raw Materials Congress

Join us at this year’s Viral Safety and Raw Materials Congress taking place in Vienna on the 24th-25th June to network and exchange with leading industry representatives, regulatory bodies and...

Read more

3rd Annual Medical Device Global Labeling Strategies

12th August 2015 - 13th August 2015

3rd Annual Medical Device Global Labeling Strategies

The marcus evans 3rd Annual Medical Device Global Labeling Strategies Conference is a highly informative, content driven forum focusing on the key fundamentals for achieving a compliant global labeling process,...

Read more

Orphan Drugs Summit

17th September 2015 - 18th September 2015

Orphan Drugs Summit

Changing times ask for solid relationships. Times are changing. A renewed interest from big pharma in the rare disease landscape has awakened due to large-scale patent expirations, competition from generics &...

Read more